MX2009009452A - Extracto bacteriano para trastornos respiratorios y proceso para su preparacion. - Google Patents

Extracto bacteriano para trastornos respiratorios y proceso para su preparacion.

Info

Publication number
MX2009009452A
MX2009009452A MX2009009452A MX2009009452A MX2009009452A MX 2009009452 A MX2009009452 A MX 2009009452A MX 2009009452 A MX2009009452 A MX 2009009452A MX 2009009452 A MX2009009452 A MX 2009009452A MX 2009009452 A MX2009009452 A MX 2009009452A
Authority
MX
Mexico
Prior art keywords
extract
respiratory disorders
proces
preparation
bacterial extract
Prior art date
Application number
MX2009009452A
Other languages
English (en)
Inventor
Jacques Alain Bauer
Marco Salvagni
Jean-Pierre Leon Vigroux
Carlo Chiavaroli
Laetitia Chalvet
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of MX2009009452A publication Critical patent/MX2009009452A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a un extracto a partir de cepas bacterianas, tales como Staphylococcus, Moraxella, Klebsiella, Streptococcus, y Haemophilus. El extracto es útil como tratamiento para indicaciones tales como trastornos respiratorios, composiciones que comprenden el extracto, y procesos para preparar el extracto a partir de medios que no presentan un riesgo de enfermedad de priones.
MX2009009452A 2007-03-05 2008-03-05 Extracto bacteriano para trastornos respiratorios y proceso para su preparacion. MX2009009452A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90478907P 2007-03-05 2007-03-05
PCT/US2008/055906 WO2008109669A2 (en) 2007-03-05 2008-03-05 Bacterial extract for respiratory disorders and proces for its preparation

Publications (1)

Publication Number Publication Date
MX2009009452A true MX2009009452A (es) 2009-09-14

Family

ID=39739087

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009452A MX2009009452A (es) 2007-03-05 2008-03-05 Extracto bacteriano para trastornos respiratorios y proceso para su preparacion.

Country Status (21)

Country Link
US (2) US8697154B2 (es)
EP (2) EP2114421B1 (es)
JP (1) JP5693010B2 (es)
KR (1) KR101527483B1 (es)
CN (1) CN101663041B (es)
AR (2) AR070307A1 (es)
AU (1) AU2008222865B2 (es)
BR (1) BRPI0808333B8 (es)
CA (1) CA2679843C (es)
DK (1) DK2114421T3 (es)
ES (1) ES2665002T3 (es)
HU (1) HUE038598T2 (es)
IL (1) IL200666A (es)
MX (1) MX2009009452A (es)
PL (1) PL2114421T3 (es)
PT (1) PT2114421T (es)
RU (1) RU2456007C2 (es)
SI (1) SI2114421T1 (es)
TW (1) TWI434693B (es)
WO (1) WO2008109669A2 (es)
ZA (1) ZA200906029B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401876D0 (sv) * 2004-07-16 2004-07-16 Forskarpatent I Syd Ab Prevention of allergy in children
GB2477752A (en) * 2010-02-11 2011-08-17 Arab Biotechnology Company Detection of bacteria
FR2969657B1 (fr) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
FR2969658B1 (fr) * 2010-12-22 2014-10-17 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
CN103157108B (zh) * 2011-12-13 2016-01-20 宁云山 免疫调节剂组合物及其药物组合物和应用
WO2013119170A2 (en) * 2012-02-08 2013-08-15 Premune Ab Prevention of inflammatory disorders in domestic non-human mammals
ES2708756T3 (es) * 2013-03-11 2019-04-11 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o el tratamiento de complicaciones pulmonares inducidas por radiación
CN105779326A (zh) * 2014-12-25 2016-07-20 河南科技学院 化脓性链球菌细胞壁成分萃取方法
CN106310246A (zh) * 2016-08-31 2017-01-11 廖正芳 一种可吸入制剂及其制备方法
KR102134385B1 (ko) 2017-02-06 2020-07-16 주식회사 한국인삼공사 홍삼 추출물을 함유하는 호흡기 증상 개선용 조성물
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
CN108785251B (zh) * 2018-01-23 2020-11-24 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用
WO2020005584A1 (en) 2018-06-28 2020-01-02 Gen-Probe Incorporated Sample preparation method and system
KR20210141546A (ko) 2019-03-14 2021-11-23 옴 파르마 에스아 안정한 박테리아 추출물 제조 공정 및 이의 약제로서의 용도
MX2021010908A (es) * 2019-03-14 2021-10-01 Om Pharma Sa Metodo para tratar y/o prevenir asma, exacerbaciones de asma, asma alergica y/o condiciones asociadas con microbiota relacionada con trastornos respiratorios.
KR102437436B1 (ko) * 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
WO2020218868A1 (ko) * 2019-04-26 2020-10-29 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532790A (en) * 1968-02-23 1970-10-06 Canadian Patents Dev Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
CH633188A5 (fr) 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
IT1199301B (it) 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
PT729473E (pt) 1993-11-17 2001-02-28 Deutsche Om Arzneimittel Gmbh Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
PT1849860E (pt) 1997-05-28 2011-02-23 Novartis Vaccines & Diagnostic Processo de preparação de um factor imunogénico de corynebacterium diphtheriae utilizando um meio de cultura com extracto de levedura como fonte de aminoácidos e sem complexos proteicos de origem animal
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
AU754256C (en) * 1997-12-23 2004-05-20 Pfizer Ireland Pharmaceuticals Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
US20010051364A1 (en) 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
JP2000319294A (ja) * 1999-05-11 2000-11-21 Asahi Chem Ind Co Ltd 生物由来高分子溶液精製方法
FR2822071B1 (fr) 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
BRPI0411815A (pt) * 2003-06-23 2006-08-08 Baxter Int vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
CA2535892A1 (en) * 2003-08-18 2005-02-24 The Bio Balance Corporation A stable liquid probiotic composition, preparation and applications thereof
EP1848448B8 (en) 2005-02-08 2010-09-15 Parmeggiani, Francesco Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse
EP1855717A4 (en) * 2005-02-11 2009-12-23 Ace Biosciences As ON THE SURFACE STREPTOCOCCUS PNEUMONIAE POLYPEPTIDE
CA2556537A1 (en) * 2005-03-03 2006-09-03 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
EP1862537B1 (en) * 2005-03-10 2013-05-08 Kyoritsu Seiyaku Corporation Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine
WO2007084856A2 (en) 2006-01-13 2007-07-26 Baxter International Inc. Method for purifying polysaccharides
EP3332806A1 (en) * 2007-03-05 2018-06-13 OM Pharma Bacterial extract for digestive or urinary tract disorders and process for its preparation

Also Published As

Publication number Publication date
CN101663041A (zh) 2010-03-03
IL200666A0 (en) 2010-05-17
ZA200906029B (en) 2010-11-24
ES2665002T3 (es) 2018-04-24
KR101527483B1 (ko) 2015-06-09
SI2114421T1 (en) 2018-04-30
EP3332791A1 (en) 2018-06-13
TW200938212A (en) 2009-09-16
CA2679843C (en) 2018-10-02
AR111836A2 (es) 2019-08-21
RU2456007C2 (ru) 2012-07-20
EP2114421A2 (en) 2009-11-11
WO2008109669A2 (en) 2008-09-12
US20140205693A1 (en) 2014-07-24
PL2114421T3 (pl) 2018-07-31
BRPI0808333B1 (pt) 2020-03-10
US9463209B2 (en) 2016-10-11
IL200666A (en) 2016-12-29
PT2114421T (pt) 2018-04-17
EP2114421B1 (en) 2018-01-10
RU2009136577A (ru) 2011-04-10
BRPI0808333B8 (pt) 2021-05-25
KR20090122940A (ko) 2009-12-01
US20100227013A1 (en) 2010-09-09
EP2114421A4 (en) 2010-09-22
TWI434693B (zh) 2014-04-21
JP5693010B2 (ja) 2015-04-01
DK2114421T3 (en) 2018-04-23
AU2008222865B2 (en) 2013-01-31
CA2679843A1 (en) 2008-09-12
JP2010520302A (ja) 2010-06-10
CN101663041B (zh) 2012-05-23
WO2008109669A3 (en) 2008-12-18
HUE038598T2 (hu) 2018-10-29
AU2008222865A1 (en) 2008-09-12
AR070307A1 (es) 2010-03-31
BRPI0808333A2 (pt) 2017-05-30
US8697154B2 (en) 2014-04-15

Similar Documents

Publication Publication Date Title
MX2009009452A (es) Extracto bacteriano para trastornos respiratorios y proceso para su preparacion.
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
WO2015095241A3 (en) Bacterial compositions and methods of use thereof for treatment of immune system disorders
MX2012004525A (es) Compuestos.
WO2011110918A8 (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
MY178156A (en) Compounds and their use as bace inhibitors
MX2013000369A (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
MX347852B (es) Cepas de bradirrizobio.
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
MY160241A (en) 5-alkynyl-pyrimidines
NZ708928A (en) Mannose derivatives for treating bacterial infections
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
WO2013033037A3 (en) Novel antiprion compounds
MX2009009451A (es) Extracto bacteriano para trastornos del tracto digestivo o uranio y proceso para su preparacion.
CA2710814C (en) Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
WO2011163500A3 (en) Methods and compositions for reducing body odor
WO2013036783A3 (en) Methods for treating intrapulmonary infections
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
WO2011060252A3 (en) Bioactive fractions from stress-induced photosynthetic organisms and methods of their manufacture and use
MX2012006799A (es) Microparticulas de antibiotico para inhalacion.
MY150931A (en) Substituted oxazolidinones and their use
PH12016501532A1 (en) Antibacterial combinations comprising polymyxin
EP2585067A4 (en) COMPOUND FOR THE TREATMENT OF ENTEROVIRUS
WO2010123599A3 (en) Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration